RELL1, a novel oncogene, accelerates tumor progression and regulates immune infiltrates in glioma.
Sign Up to like & getrecommendations! Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106707
Abstract: BACKGROUND Diffuse gliomas are the most prevalent primary brain tumors. The Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) databases provide evidence of the relationships between gliomas and altered molecular pathways. In… read more here.
Keywords: tumor progression; novel oncogene; oncogene accelerates; rell1 ... See more keywords